Direct proteomic mapping of Streptomyces avermitilis wild and industrial strain and insights into avermectin production. 2013

Peng Yin, and You-Yuan Li, and Jin Zhou, and Yong-Hong Wang, and Si-Liang Zhang, and Bang-Ce Ye, and Wei-Feng Ge, and Yue-Lan Xia
State Key Laboratory of Bioreactor Engineering, National Research Center for Biotechnology, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, China.

An industrial mutant of Streptomyces avermitilis produced avermectin at a high level in industrial complex culture medium. However, almost no avermectin was detected in the cultures of tryptone soya broth (TSB). Its wild-type strain could not synthesize avermectin. To elucidate the regulatory mechanism about avermectin production, proteomic analysis of S. avermitilis was carried out. Results showed that during avermectin biosynthesis, fatty acid metabolism and TCA cycle were repressed. Partial enrichment of glycolytic pathway indicated the critical role of glucose catabolism during avermectin biosynthesis. Some enriched enzymes in amino acid metabolic pathways (glnA, leuC) confirmed the leucine as the possible precursor of avermectin. Highly expressed stress or stress-related proteins indicated a global regulation mechanism at the onset of avermectin production. And highly expressed morphology control proteins revealed an association between hyphal morphology and avermectin production. Further, this study proofed strengthened capability to utilize carbon and nitrogen source in the industrial strain. Some stress or stress-related proteins (eshA, clpC, dnaK and grpE) expressed at low level in the industrial strain cultivated in non-production medium (lower than that in the wild-type strain), but these highly expressed at the onset of avermectin production. More sensible response to environmental stress may be responsible for it.

UI MeSH Term Description Entries
D007559 Ivermectin A mixture of mostly avermectin H2B1a (RN 71827-03-7) with some avermectin H2B1b (RN 70209-81-3), which are macrolides from STREPTOMYCES avermitilis. It binds glutamate-gated chloride channel to cause increased permeability and hyperpolarization of nerve and muscle cells. It also interacts with other CHLORIDE CHANNELS. It is a broad spectrum antiparasitic that is active against microfilariae of ONCHOCERCA VOLVULUS but not the adult form. Eqvalan,Ivomec,MK-933,Mectizan,Stromectol,MK 933,MK933
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.
D015964 Gene Expression Regulation, Bacterial Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria. Bacterial Gene Expression Regulation,Regulation of Gene Expression, Bacterial,Regulation, Gene Expression, Bacterial
D020543 Proteome The protein complement of an organism coded for by its genome. Proteomes
D040901 Proteomics The systematic study of the complete complement of proteins (PROTEOME) of organisms. Peptidomics

Related Publications

Peng Yin, and You-Yuan Li, and Jin Zhou, and Yong-Hong Wang, and Si-Liang Zhang, and Bang-Ce Ye, and Wei-Feng Ge, and Yue-Lan Xia
January 2005, Journal of proteome research,
Peng Yin, and You-Yuan Li, and Jin Zhou, and Yong-Hong Wang, and Si-Liang Zhang, and Bang-Ce Ye, and Wei-Feng Ge, and Yue-Lan Xia
December 2009, Canadian journal of microbiology,
Peng Yin, and You-Yuan Li, and Jin Zhou, and Yong-Hong Wang, and Si-Liang Zhang, and Bang-Ce Ye, and Wei-Feng Ge, and Yue-Lan Xia
February 1988, Antimicrobial agents and chemotherapy,
Peng Yin, and You-Yuan Li, and Jin Zhou, and Yong-Hong Wang, and Si-Liang Zhang, and Bang-Ce Ye, and Wei-Feng Ge, and Yue-Lan Xia
March 2019, Synthetic and systems biotechnology,
Peng Yin, and You-Yuan Li, and Jin Zhou, and Yong-Hong Wang, and Si-Liang Zhang, and Bang-Ce Ye, and Wei-Feng Ge, and Yue-Lan Xia
June 2005, Journal of microbiology (Seoul, Korea),
Peng Yin, and You-Yuan Li, and Jin Zhou, and Yong-Hong Wang, and Si-Liang Zhang, and Bang-Ce Ye, and Wei-Feng Ge, and Yue-Lan Xia
January 2017, Microbial cell factories,
Peng Yin, and You-Yuan Li, and Jin Zhou, and Yong-Hong Wang, and Si-Liang Zhang, and Bang-Ce Ye, and Wei-Feng Ge, and Yue-Lan Xia
October 2011, Applied microbiology and biotechnology,
Peng Yin, and You-Yuan Li, and Jin Zhou, and Yong-Hong Wang, and Si-Liang Zhang, and Bang-Ce Ye, and Wei-Feng Ge, and Yue-Lan Xia
December 1987, Journal of bacteriology,
Peng Yin, and You-Yuan Li, and Jin Zhou, and Yong-Hong Wang, and Si-Liang Zhang, and Bang-Ce Ye, and Wei-Feng Ge, and Yue-Lan Xia
January 2023, Applied microbiology and biotechnology,
Peng Yin, and You-Yuan Li, and Jin Zhou, and Yong-Hong Wang, and Si-Liang Zhang, and Bang-Ce Ye, and Wei-Feng Ge, and Yue-Lan Xia
May 2014, Journal of bioscience and bioengineering,
Copied contents to your clipboard!